Estadístiques de Best treatment option for patients with refractory aggressive B-cell lymphoma in the CAR-T cell era: real-world evidence from GELTAMO/GETH Spanish Groups
Visites totals
| views | |
|---|---|
| Best treatment option for patients with refractory aggressive B-cell lymphoma in the CAR-T cell era: real-world evidence from GELTAMO/GETH Spanish Groups | 74 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| bastos-fri-best.pdf(legacy) | 42 |
| bastos-fri-best.pdf | 34 |
Vistes principals per país
| views | |
|---|---|
| United States | 56 |
| Belgium | 8 |
| Australia | 2 |
| China | 2 |
| Ukraine | 2 |
| Germany | 1 |
| Spain | 1 |
| Mongolia | 1 |
| Serbia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Boardman | 9 |
| Menlo Park | 7 |
| Mountain View | 5 |
| San Ramon | 5 |
| Ann Arbor | 4 |
| Ashburn | 3 |
| Fairfield | 2 |
| San Mateo | 2 |
| Barcelona | 1 |
| Beograd | 1 |
| Cambridge | 1 |
| Dearborn | 1 |
| Inverloch | 1 |
| Pinjarra | 1 |
| Rochester | 1 |
| San Diego | 1 |
| Shenzhen | 1 |
| Sükhbaatar | 1 |